Neuroepithelial transforming gene 1 functions as a potential prognostic marker for patients with non-small cell lung cancer

Fang,Li; Zhu,Jialiang; Ma,Yuchao; Hong,Cao; Xiao,Sheng; Jin,Longyu

doi:10.3892/mmr.2015.4385

Neuroepithelial transforming gene 1 functions as a potential prognostic marker for patients with non-small cell lung cancer

Authors:
- Li Fang
- Jialiang Zhu
- Yuchao Ma
- Cao Hong
- Sheng Xiao
- Longyu Jin
View Affiliations

Affiliations: Department of Cardiothoracic Surgery, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, P.R. China, Department of Pathology, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, P.R. China
Published online on: September 29, 2015 https://doi.org/10.3892/mmr.2015.4385
Pages: 7439-7446

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Non-small cell lung cancer (NSCLC) is the most common histological cancer sub‑type worldwide. Neuroepithelial transforming gene 1 (Net-1), a Ras homolog family member A-specific guanine nucleotide exchange factor, has been shown to be upregulated in several human cancer types. However, the clinical significance of Net‑1 expression in NSCLC has remained elusive. The present study assessed Net‑1 mRNA and protein levels by reverse-transcription quantitative polymerase chain reaction and western blot analysis of 64 cases of NSCLC as well as their adjacent normal tissues. Furthermore, Net‑1 protein expression in tumor tissues derived from clinically annotated NSCLC cases at stages I‑III was detected by immunohistochemical staining. The results showed that Net‑1 mRNA and protein levels in NSCLC tissues were significantly elevated compared with those in their corresponding non‑tumor tissues. In addition, Net‑1 expression was strongly associated with the patients' pathological characteristics, including clinical stage, lymph node metastasis, distant metastasis and differentiation degree (P<0.05). In conclusion, the results of the present study suggested that Net‑1 expression has a significant role in the tumorigenesis of distinct histotypes and sub‑types of NSCLC, and may therefore be utilized as a biomarker as well as an important therapeutic target in NSCLC.

View Figures

View References

1	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
2	Herbst RS, Heymach JV and Lippman SM: Lung cancer. N Engl J Med. 359:1367–1380. 2008. View Article : Google Scholar : PubMed/NCBI
3	Gong H, Han S, Yao H, Zhao H and Wang Y: AP4 predicts poor prognosis in nonsmall cell lung cancer. Mol Med Rep. 10:336–340. 2014.PubMed/NCBI
4	Reck M: What future opportunities may immuno-oncology provide for improving the treatment of patients with lung cancer? Ann Oncol. 23(Suppl 8): viii28–viii34. 2012. View Article : Google Scholar : PubMed/NCBI
5	Chan AM, Takai S, Yamada K and Miki T: Isolation of a novel oncogene, NET-1, from neuroepithelioma cells by expression cDNA cloning. Oncogene. 12:1259–1266. 1996.PubMed/NCBI
6	Rossman KL, Der CJ and Sondek J: GEF means go: Turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol. 6:167–180. 2005. View Article : Google Scholar : PubMed/NCBI
7	Yauch RL and Hemler ME: Specific interactions among trans-membrane 4 superfamily (TM4SF) proteins and phosphoinositide 4-kinase. Biochem J. 351:629–637. 2000. View Article : Google Scholar
8	Leyden J, Murray D, Moss A, Arumuguma M, Doyle E, McEntee G, O'Keane C, Doran P and MacMathuna P: Net-1 and Myeov: Computationally identified mediators of gastric cancer. Br J Cancer. 94:1204–1212. 2006. View Article : Google Scholar : PubMed/NCBI
9	Murray D, Horgan G, Macmathuna P and Doran P: NET-1-mediated RhoA activation facilitates lysophosphatidic acid-induced cell migration and invasion in gastric cancer. Br J Cancer. 99:1322–1329. 2008. View Article : Google Scholar : PubMed/NCBI
10	Ecimovic P, Murray D, Doran P, McDonald J, Lambert DG and Buggy DJ: Direct effect of morphine on breast cancer cell function in vitro: Role of the NET-1 gene. Br J Anaesth. 107:916–923. 2011. View Article : Google Scholar : PubMed/NCBI
11	Wang GL, Chen L, Wei YZ, Zhou JM, Wu YY, Zhang YX, Qin J and Zhu YY: The effect of NET-1 on the proliferation, migration and endocytosis of the SMMC-7721 HCC cell line. Oncol Rep. 27:1944–1952. 2012.PubMed/NCBI
12	Abba MC, Hu Y, Sun H, Drake JA, Gaddis S, Baggerly K, Sahin A and Aldaz CM: Gene expression signature of estrogen receptor alpha status in breast cancer. BMC Genomics. 6:372005. View Article : Google Scholar : PubMed/NCBI
13	Zhang J, Wang J, Chen L, Wang G, Qin J, Xu Y and Li X: Expression and function of NET-1 in human skin squamous cell carcinoma. Arch Dermatol Res. 306:385–397. 2014. View Article : Google Scholar :
14	Lahiff C, Schilling C, Cathcart MC, Mulligan N, Doran P, Muldoon C, Murray D, Pidgeon GP, Reynolds JV and Macmathuna P: Prognostic significance of neuroepithelial transforming gene 1 in adenocarcinoma of the oesophagogastric junction. Br J Surg. 101:55–62. 2014. View Article : Google Scholar : PubMed/NCBI
15	Papadimitriou E, Vasilaki E, Vorvis C, Iliopoulos D, Moustakas A, Kardassis D and Stournaras C: Differential regulation of the two RhoA-specific GEF isoforms Net-1/Net-1A by TGF-β and miR-24: Role in epithelial- to -mesenchymal transition. Oncogene. 31:2862–2875. 2012. View Article : Google Scholar
16	Lee J, Moon HJ, Lee JM and Joo CK: Smad3 regulates Rho signaling via NET1 in the transforming growth factor-beta-induced epithelial-mesenchymal transition of human retinal pigment epithelial cells. J Biol Chem. 285:26618–26627. 2010. View Article : Google Scholar : PubMed/NCBI
17	Shen X, Li J, Hu PP, Waddell D, Zhang J and Wang XF: The activity of guanine exchange factor NET1 is essential for transforming growth factor-beta-mediated stress fiber formation. J Biol Chem. 276:15362–15368. 2001. View Article : Google Scholar : PubMed/NCBI
18	Travis WD, Garg K, Franklin WA, Wistuba II, Sabloff B, Noguchi M, Kakinuma R, Zakowski M, Ginsberg M, Padera R, et al: Bronchioloalveolar carcinoma and lung adeno-carcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria. J Thorac Oncol. 9:S13–9. 2006. View Article : Google Scholar
19	Travis WD, Brambilla E, Noguchi M, et al: International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. Proc Am Thorac Soc. 8:381–385. 2011. View Article : Google Scholar : PubMed/NCBI
20	Jin L, Li C, Xu Y, Wang L, Liu J, Wang D, Hong C, Jiang Z, Ma Y, Chen Q and Yu F: Epigallocatechin gallate promotes p53 accumulation and activity via the inhibition of MDM2-mediated p53 ubiquitination in human lung cancer cells. Oncol Rep. 29:1983–1990. 2013.PubMed/NCBI
21	Birner P, Oberhuber G, Stani J, Reithofer C, Samonigg H, Hausmaninger H, Kubista E, Kwasny W, Kandioler-Eckersberger D, Gnant M, et al: Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer. Clin Cancer Res. 7:1669–1675. 2001.PubMed/NCBI
22	Mirsadraee S, Oswal D, Alizadeh Y, Caulo A and van Beek E Jr: The 7th lung cancer TNM classification and staging system: Review of the changes and implications. World J Radiol. 4:128–134. 2012. View Article : Google Scholar : PubMed/NCBI
23	Bennett G, Sadlier D, Doran PP, Macmathuna P and Murray DW: A functional and transcriptomic analysis of NET-1 bioactivity in gastric cancer. BMC Cancer. 11:502011. View Article : Google Scholar
24	Shen SQ, Li K, Zhu N and Nakao A: Expression and clinical significance of NET-1 and PCNA in hepatocellular carcinoma. Med Oncol. 25:341–345. 2008. View Article : Google Scholar : PubMed/NCBI
25	Tu Y, Lu J, Fu J, Cao Y, Fu G, Kang R, Tian X and Wang B: Over-expression of neuroepithelial-transforming protein 1 confers poor prognosis of patients with gliomas. Jpn J Clin Oncol. 40:388–394. 2010. View Article : Google Scholar : PubMed/NCBI
26	Wollscheid V, Kühne-Heid R, Stein I, Jansen L, Köllner S, Schneider A and Dürst M: Identification of a new proliferation-associated protein NET-1/C4.8 characteristic for a subset of high-grade cervical intraepithelial neoplasia and cervical carcinomas. Int J Cancer. 99:771–775. 2002. View Article : Google Scholar : PubMed/NCBI